[Prevention of cytomegalovirus infection and disease in the transplantation patient].
Cisneros
J M
JM
Unidad de Enfermedades Infecciosas, Hospital Universitario Virgen del Rocio, Sevilla.
Pachón
J
J
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000517:prevention & control* / Q000635:transmission; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D011024:Pneumonia, Viral / Q000382:microbiology / Q000517:prevention & control; D011658:Pulmonary Fibrosis / Q000382:microbiology / Q000517:prevention & control; D009927:Tissue and Organ Procurement / Q000592:standards; D014180:Transplantation / Q000009:adverse effects*
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D015774:Ganciclovir; D000212:Acyclovir